1. National Kidney Foundation Spring Clinical Meeting 2020, New Orleans, LA. March 25-29.

https://www.kidney.org/spring-clinical

Thursday March 26, 2020, 4:45-5:15 PM. Late Breaking Abstract Presentation presented by Dr. Kamyar Kalantar-Zadeh, MD

Apabetalone reduces Cardiovascular Events in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Recent Acute Coronary Syndrome: A BETonMACE trial report

2. American College of Cardiology 2020 together with World Congress of Cardiology 2020, Chicago, IL. March 28-30. 

https://accscientificsession.acc.org/

March 29, 2020, Poster Session 12:00-2:00 PM: Session 1315 - Acute and Stable Ischemic Heart Disease: Clinical 5. Presenting author is Dr. Stephen J. Nicholls. This one is not moderated like the one below, but Dr. Nicholls will be present at the poster during 12:30-1:15 PM according to schedule. 

1315-168 / 168 - THE BET PROTEIN INHIBITOR APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND DIABETES: RESULTS FROM THE BETONMACE TRIAL

https://www.abstractsonline.com/pp8/#!/8992/session/875

3. American College of Cardiology 2020 together with World Congress of Cardiology 2020, Chicago, IL. March 28-30. 

https://accscientificsession.acc.org/

March 30, 2020, Moderated Poster Session 10:00-10:10 AM. Session 1080 - Vascular Basic Science. Presenting author is Dr. Sylwia Wasiak, PhD. Followed by 5 minutes of moderated Q&A 10:10-10:15 AM.

1080-05 - EPIGENETIC READER INHIBITOR APABETALONE (RVX-208) COUNTERS PROINFLAMMATORY HYPERACTIVATION OF CD14+ MONOCYTES FROM PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE

https://www.abstractsonline.com/pp8/#!/8992/presentation/12275